Elevated Lipoprotein(a), also called Lp(a), is a type of cholesterol that can increase the risk of heart problems. When Lp(a) levels are high, it can lead to the buildup of plaque in the arteries, which may cause heart attacks or strokes. Unlike other types of cholesterol, Lp(a) levels are mostly inherited and cannot be easily controlled through diet or exercise. People with high Lp(a) are considered at greater risk for serious cardiovascular events, so regular check-ups and early detection are important.
An upcoming clinical trial will test a new oral medication designed to lower elevated Lipoprotein(a) levels in adults at high risk for cardiovascular events. This once-daily treatment is being studied for both its effectiveness and safety. The goal is to determine whether the medication can safely reduce Lp(a) levels and help prevent serious heart-related complications in the future.
